Good Start Genetics is dedicated to helping grow healthy families through its best-in-class genetics offerings. Using advanced clinical sequencing, proprietary methods and information tailored to the individual, the Company's suite of offerings arms clinicians and patients with insightful and actionable information to promote successful pregnancies and help build healthy families. The Company’s product portfolio, including GeneVu, EmbryVu and VeriYou, encompasses a multifaceted approach to genetic testing, featuring solutions for both preimplantation and carrier screening, while offering comprehensive and flexible testing options helping a wider range of couples find their paths to pregnancy at significantly lower costs. Good Start Genetics complements these offerings with world class customer care and genetic counseling to help families stay well-informed and be better prepared for tomorrow. For more information, please visit www.goodstartgenetics.com or join us on Facebook, Twitter and LinkedIn.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $60M
Founded date: 2008
Founders name: Uri Laserson
Founders Related Locations: United States, New York, New York
Investors 1
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.05.2013 | - | $28M | - |
| 02.04.2012 | Series B | $14M | - |
| 10.09.2010 | - | $18M | - |
Mentions in press and media 15
| Date | Title | Description |
| 15.05.2017 | Carrier screening through Amazon? Good Start Genetics expands its online presence | The tests belong to Good Start Genetics, a Cambridge, Massachusetts-based company that first partnered with Amazon in November 2016. Good Start is part of a growing class of companies that use next-generation sequencing to understand a coup... |
| 16.05.2013 | Cambridge firm uses next-generation DNA sequencing to detect more mutations in carrier screening | Carrier screening has been around for a while, and many women undergo screening before or during pregnancy for certain hereditary disorders associated with their ethnic background. The Associated Press in 2010 found that many inherited dise... |
| 08.05.2013 | Good Start Genetics Closes $28M Loan | Good Start Genetics, Inc., a Cambridge MA-based molecular diagnostics company, closed a non-dilutive loan facility for up to $28m of capital from Capital Royalty L.P. The company intends to use the funds to support its long-term corporate g... |
| 08.05.2013 | Good Start Genetics Inks $28M in Venture Debt | CAMBRIDGE, MA, Innovative molecular diagnostics company announced that it has closed a non-dilutive loan facility for up to $28 million of capital from Capital Royalty. >> Click here for more funding data on Good Start Genetics &g... |
| 26.10.2012 | 3 companies that reflect Safeguard Scientifics’ healthcare investments | Jim Datin, the executive vice president, explained that it has seen valuations coming down in the healthcare sector “particularly those companies that need a high amount of capital for either commercial launches or getting products approved... |
| 02.04.2012 | Good Start Genetics Announces $14M Series B | CAMBRIDGE, MA, Molecular diagnostics company developing the new gold standard in carrier screening, announced it completed the initial closing of a $14 million Series B Preferred Stock financing. >> Click here for more funding data... |
| 02.04.2012 | Good Start Genetics Raises $14m in Series B Financing | Good Start Genetics, a Cambridge, Mass.-based molecular diagnostics company, has raised $14m in Series B financing. The round was led by existing investors OrbiMed Advisors, Safeguard Scientifics, and SV Life Sciences. The company intends t... |
| 10.09.2010 | Good Start Genetics Raises $18M | Good Start Genetics, Inc. , a Boston, MA-based provider of clinically relevant genetic information to physicians , finalized an $18m Series A financing. The round was led by OrbiMed Advisors, Safeguard Scientifics, Inc. (NYSE: SFE) and SV L... |
| 10.09.2010 | Good Start Genetics drums up $18 million | Good Start Genetics Inc. closed an $18 million Series A funding round and tapped former Exact Sciences Corp. (NSDQ:EXAS) head Don Hardison to be its president and CEO. The Boston-based company is developing a pre-pregnancy genetic test desi... |
| 10.09.2010 | Good Start Genetics raises $18M for pre-pregnancy genetic test | “The chips that have been built typically look for those 23 mutations. The problem is that there are 1,700 mutations associated with cystic fibrosis. We sequence the entire gene,” Hardison told us. “You’re going to have a better idea if you... |
Show more